Delirium subtype was specified in 34 delirious patients. 11.8% HD No significant difference in S100B protein or Neuron Specific Enolase levels was seen between delirium subtypes. There were no differences in cognitive impairment among different subtype delirious patients
22% HD in dementia patients 41% HD in nondementia patients No differences in mortality between delirium subtypes during hospitalization and at one-year follow-up